Patent · US Expired

Azaindoles, preparation processes and medicinal products containing them

US5338849A · kind A · utility

86Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 1993
Grant dateAug 16, 1994
Priority date
Expiry dateFeb 4, 2013

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

These compounds correspond to the formula ##STR1## in which one of the groups X.sub.1 to X.sub.4 represents nitrogen and the others a CH radical, PA1 R.sub.1 and R.sub.2 represent H, halogen, alkyl, hydroxymethyl, alkyloxymethyl, dialkylaminoalkyl, dialkylaminoalkyloxymethyl, carboxyl, ethyl carboxylate, piperidino, alkenyl, cycloalkyl, cycloalkenyl, alkylthio, benzyl, phenyl, thiophene or pyridine, optionally substituted, PA1 R.sub.3 and R.sub.4 represent H, halogen, alkyl, cycloalkyl, alkoxy or alkylthio, PA1 R.sub.5 and R.sub.6 denote H, alkyl, alkenyl, cycloalkyl, cycloalkenyl, alkoxyalkyl or alkylthioalkyl, or together form alkylene or alkyleneoxyalkylene chains, PA1 R.sub.7 denotes H, alkyl or cycloalkyl; one of the radicals R.sub.5 to R.sub.7 can also denote optionally substituted phenyl or benzyl, PA1 R.sub.8 represents H, alkyl, cycloalkyl or optionally substituted phenyl or benzyl, PA1 R.sub.9 denotes optionally substituted phenyl, naphthyl or heterocyclic, PA1 as well as their tautomeric forms, processes for preparing them and application as hypolipidaemic and antiatheromatous medicinal products.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.